Syros Pharmaceuticals, Inc.

SYRS · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$58,275$78,964$83,523$139,526
Short-Term Investments$0$0$24,781$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,656$5,957$3,898$5,454
Total Curr. Assets$63,931$84,921$112,202$144,980
Property Plant & Equip (Net)$17,579$18,222$18,857$19,483
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,119$2,119$2,119$2,119
Tax Assets$0$0$0$0
Other NC Assets$1,366$1,460$1,550$1,592
Total NC Assets$21,064$21,801$22,526$23,194
Other Assets$0$0$0$0
Total Assets$84,995$106,722$134,728$168,174
Liabilities
Payables$9,646$7,469$11,346$11,544
Short-Term Debt$0$2,495$11,667$6,667
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$0$1,320$0$9,153
Total Curr. Liab.$28,392$24,521$37,303$36,681
LT Debt$41,081$40,934$29,708$34,556
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$10,084$30,387$34,773$61,747
Total NC Liab.$67,726$88,553$82,368$114,831
Other Liabilities$0$0$0$0
Cap. Leases$19,145$17,232$17,887$18,528
Total Liabilities$96,118$113,074$119,671$151,512
Equity
Pref Stock$0$0$0$0
Common Stock$27$26$26$26
Retained Earnings-$756,238-$749,842-$726,515-$722,807
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity-$11,123-$6,352$15,057$16,662
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$84,995$106,722$134,728$168,174
Net Debt-$17,194-$35,535-$42,148-$98,303
Syros Pharmaceuticals, Inc. (SYRS) Financial Statements & Key Stats | AlphaPilot